Dasatinib for the treatment of Philadelphia chromosome-positive leukaemias (vol 16, pg 679, 2007)

被引：0
|
作者：
Jabbour
Cortes
Kantarjian
机构：
来源：
EXPERT OPINION ON INVESTIGATIONAL DRUGS | 2007年 / 16卷 / 07期
关键词：
D O I：
10.1517/13543784.16.7.1135
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1135 / 1135
页数：1
相关论文
共 50 条
  • [21] Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    Iman Abou Dalle
    Elias Jabbour
    Nicholas J. Short
    Farhad Ravandi
    Current Treatment Options in Oncology, 2019, 20
  • [22] Spotlight on dasatinib in chronic myeloid leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia
    McCormack P.L.
    Keam S.J.
    BioDrugs, 2012, 26 (1) : 61 - 64
  • [23] SEVERE HEMORRHAGIC COLITIS CAUSED BY DASATINIB IN PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA
    Shimokaze, Tomoyuki
    Mitsui, Tetsuo
    Takeda, Hiroaki
    Kawakami, Takako
    Arai, Takahiko
    Ito, Masafumi
    Iwaba, Akiko
    Izumino, Hiroko
    Takahashi, Noriyuki
    Kanno, Miyako
    Sendo, Dai
    Hayasaka, Kiyoshi
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2009, 26 (06) : 448 - 453
  • [24] Spotlight on Dasatinib in Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    McCormack, Paul L.
    Keam, Susan J.
    BIODRUGS, 2012, 26 (01) : 61 - 64
  • [25] Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome-positive ALL
    Rousselot, Philippe
    Coude, Marie Magdelaine
    Gokbuget, Nicola
    Passerini, Carlo Gambacorti
    Hayette, Sandrine
    Cayuela, Jean-Michel
    Huguet, Francoise
    Leguay, Thibaut
    Chevallier, Patrice
    Salanoubat, Celia
    Bonmati, Caroline
    Alexis, Magda
    Hunault, Mathilde
    Glaisner, Sylvie
    Agape, Philippe
    Berthou, Christian
    Jourdan, Eric
    Fernandes, Jose
    Sutton, Laurent
    Banos, Anne
    Reman, Oumedaly
    Lioure, Bruno
    Thomas, Xavier
    Ifrah, Norbert
    Lafage-Pochitaloff, Marina
    Bornand, Anne
    Morisset, Laure
    Robin, Valerie
    Pfeifer, Heike
    Delannoy, Andre
    Ribera, Josep
    Bassan, Renato
    Delord, Marc
    Hoelzer, Dieter
    Dombret, Herve
    Ottmann, Oliver G.
    BLOOD, 2016, 128 (06) : 774 - 782
  • [26] Remission of Philadelphia chromosome-positive central nervous system leukemia after dasatinib therapy
    Abdelhalim, Ahmed
    Barcos, Maurice
    Block, Annemarie W.
    Sait, Sheila N. J.
    Starostik, Petr
    Wetzler, Meir
    Wang, Eunice S.
    LEUKEMIA & LYMPHOMA, 2007, 48 (05) : 1053 - 1056
  • [27] Dasatinib: A tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia
    Steinberg, Michael
    CLINICAL THERAPEUTICS, 2007, 29 (11) : 2289 - 2308
  • [28] Dasatinib A Review of its Use in the Treatment of Chronic Myeloid Leukaemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia
    McCormack, Paul L.
    Keam, Susan J.
    DRUGS, 2011, 71 (13) : 1771 - 1795
  • [29] Ponatinib in Philadelphia Chromosome-Positive Leukemias
    Quintas-Cardama, Alfonso
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (06): : 577 - 577
  • [30] Current treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia
    Fielding, Adele K.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (01): : 8 - 12
12345